Triple-negative breast cancer (TNBC) represents one specific type of breast cancer that lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2). This evidence concerns the gene ERBB2 and breast carcinoma.